Co-Processed Excipients in Pharmaceutical Formulation: Advances, Characterization, and Applications

Abstract

Excipients are indispensable components of pharmaceutical dosage forms, significantly influencing product quality, safety, and performance. Conventional single excipients often fail to meet the growing demands of modern formulation technologies, particularly direct compression and fast dissolving dosage forms. Co-processed excipients have emerged as a novel class of multifunctional excipients developed by physically combining two or more excipients at the sub-particle level without altering their chemical structure. This approach results in synergistic improvement in flowability, compressibility, dilution potential, and disintegration behavior. Various techniques such as spray drying, melt granulation, solvent evaporation, and co-crystallization are employed in the preparation of co-processed excipients. Comprehensive characterization using micromeritic, physicochemical, and solid-state techniques is essential to ensure quality and performance. Co-processed excipients have found extensive applications in direct compression tablets, fast dissolving tablets, immediate-release, and modified-release dosage forms. Despite their advantages, regulatory challenges and limited pharmacopoeial recognition remain key concerns. This review highlights the principles, preparation methods, characterization techniques, applications, commercially available products, regulatory aspects, and future prospects of co-processed excipients.

Introduction

Pharmaceutical excipients play a vital role in the development of safe, effective, and stable dosage forms. Traditionally, excipients are selected to perform individual functions such as filling, binding, disintegration, lubrication, or flow enhancement [1]. However, the increasing complex15, 1706, 1510, 97-10415, 1706, 1510, 97-104ity of drug molecules and preference for cost-effective manufacturing techniques such as direct compression have highlighted the limitations of conventional excipients [2].

Direct compression requires excipients with excellent flowability, compressibility, and dilution potential. Many active pharmaceutical ingredients (APIs) exhibit poor flow and compaction properties, making formulation development challenging [3]. To overcome these limitations, co-processed excipients were introduced as a novel approach to enhance excipient functionality without chemical modification [4].

Rationale for Co-Processing of Excipients

Although physical mixtures of excipients are widely used, they often suffer from segregation, non-uniform distribution, and inconsistent performance during compression [5]. In addition, the use of multiple excipients increases formulation complexity and manufacturing variability. Co-processing offers a solution by engineering excipients at the particle level to achieve synergistic functionality. By combining excipients with complementary deformation behaviors, such as brittle fracture and plastic deformation, co-processed excipients exhibit superior compaction behavior and mechanical strength compared to physical mixtures [6-9].

Concept and Principles of Co-Processed Excipients

Co-processed excipients are defined as combinations of two or more excipients processed together to improve functional properties while retaining their original chemical identity [10]. Unlike novel excipients, co-processed excipients do not involve chemical modification, which simplifies regulatory acceptance. The principle of co-processing lies in particle engineering, where particle size distribution, porosity, surface morphology, and bonding properties are optimized. Proper selection of parent excipients with complementary properties is essential to achieve enhanced flow, compressibility, and disintegration behavior [11-15].

Methods of Preparation of Co-Processed Excipients

1. Spray Drying

Spray drying is the most widely used technique for preparing co-processed excipients due to its scalability and reproducibility. It produces spherical and porous particles with improved flowability and compressibility [17].

2. Solvent Evaporation

In this method, excipients are dissolved or dispersed in a common solvent followed by solvent removal. Although it ensures intimate mixing, residual solvent concerns limit its industrial applicability [18].

3. Melt Granulation

Melt granulation involves agglomeration of excipients using a meltable binder. This solvent-free technique improves compactibility and tablet strength and is suitable for thermally stable excipients [19].

4. Co-Crystallization

Co-crystallization produces crystalline systems with modified physical properties such as improved compactibility and stability. However, process complexity limits its widespread industrial use [20].

Download the full article as PDF here Co-Processed Excipients in Pharmaceutical Formulation: Advances, Characterization, and Applications

or continue reading here

Table 6: Marketed Formulations of Co-Processed Excipients [33]

Amar M. Raval, Prathmesh R Bhavsar, Foram U Pandya, & Dr. Divyakant Patel. (2026). Co-Processed Excipients in Pharmaceutical Formulation: Advances, Characterization, and Applications. Asian Journal of Pharmaceutical Research and Development, 14(01), 105–113. https://doi.org/10.22270/ajprd.v14i01.1705 (Original work published February 15, 2026)

See also our article:

EMA Document: Questions and Answers regarding co-processed excipients used in solid oral dosage forms (H & V)